Investors
List of the current and past investors into Biovex Inc with their respective financial instruments.Investor | Profile | Country | Phone | Round | |||
---|---|---|---|---|---|---|---|
![]() |
Amgen Inc | United States | +1 (805) 447-1000 | Acquisition | |||
![]() |
Avalon Ventures | United States | +1 (858) 348-2180 | N/A | |||
![]() |
Avalon Ventures | United States | +1 (858) 348-2180 | Series E | |||
![]() |
Beringea LLC | Transatlantic venture capital firm. | United States | +1 (248) 489-9000 | N/A | ||
![]() |
Crédit Agricole Private Equity | France | Series F | ||||
![]() |
Crédit Agricole Private Equity | France | Series E | ||||
![]() |
Excalibur Fund Managers Ltd | United Kingdom | +44 (20) 7887-7642 | N/A | |||
![]() |
Forbion Capital Partners | Netherlands | +31 (35) 699-3000 | Series F | |||
![]() |
Forbion Capital Partners | Netherlands | +31 (35) 699-3000 | Series E | |||
![]() |
GeneChem Management Inc | Venture capital firm targeting companies in the genomics industry | Canada | +1 (514) 849-7696 | Series E | ||
![]() |
GeneChem Management Inc | Venture capital firm targeting companies in the genomics industry | Canada | +1 (514) 849-7696 | N/A | ||
![]() |
Harris & Harris Group Inc (HHVC) | Internally managed venture capital company specializing in nanotechnology and microsystems | United States | +1 (212) 582-0900 | Series F | ||
![]() |
Innoven Partenaires SA | France | +33 (1) 4703-1818 | Series F | |||
![]() |
Innoven Partenaires SA | France | +33 (1) 4703-1818 | Series E | |||
![]() |
Lloyds TSB Development Capital Ltd (LDC) | The private equity arm of Lloyds Banking Group. | United Kingdom | +44 (117) 360-1970 | N/A | ||
![]() |
Morningside Group | China | +852 2894-9800 | N/A | |||
![]() |
MVM Life Science Partners LLP | Venture capital firm which invests in technologies and products for the life science and healthcare markets | United Kingdom | +44 (20) 7557-7500 | N/A | ||
![]() |
New Science Ventures (NSV) | Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. | United States | Series F | |||
![]() |
New Science Ventures (NSV) | Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. | United States | Series E | |||
![]() |
Omega Fund Management UK LLP | United Kingdom | N/A | ||||
![]() |
Scottish Equity Partners LLP (SEP) | United Kingdom | +44 (141) 273-4000 | Series F | |||
![]() |
Scottish Equity Partners LLP (SEP) | United Kingdom | +44 (141) 273-4000 | Series E | |||
![]() |
Sectoral Asset Management Inc | Canada | N/A | ||||
![]() |
Triathlon Medical Ventures LLC | United States | Series F | ||||
![]() |
Triathlon Medical Ventures LLC | United States | Series E | ||||
![]() |
Ventech SA | France | N/A | ||||
![]() |
Ysios Capital Partners SGECR SA | Spanish venture capital firm focused on the healthcare space. | Spain | +34 (93) 403-9772 | N/A |